by David Page, CHS National Director of Health Policy Given recent advances in therapies for inherited bleeding disorders, especially hemophilia A and B, I have...
CLICK HERE to access the November 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
CLICK HERE to access the CHS 2020 Annual Report and the complete Financial Statements.
Ferring says supply of DDAVP injectable to return in “one to two months” Montreal, June 23, 2021 – Ferring Canada, in discussions with the Canadian...
CLICK HERE to access the June 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
